PCSK9 and neoplasm: Gene knockout or PCSK9 antibody inhibition increases the expression of MHC‐I proteins on the tumor cell surface, promoting strong infiltration of cytotoxic T cells within tumors and enhancing the efficacy of anti‐PD1 therapies [208].